Resverlogix Corp. (RVX.TO)
| Previous Close | 0.0500 |
| Open | 0.0500 |
| Bid | 0.0500 x 0 |
| Ask | 0.0550 x 0 |
| Day's Range | 0.0500 - 0.0500 |
| 52 Week Range | 0.0400 - 0.1100 |
| Volume | |
| Avg. Volume | 32,200 |
| Market Cap | 13.741M |
| Beta (5Y Monthly) | 0.71 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0500 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Baystreet
Stocks in play: Resverlogix Corp.
Has entered into definitive transaction documents for the two-year extension of the Company's US$6.0 ...
NewsfileResverlogix Provides Update Regarding Two-Year Extension of Debenture and Elimination of Conversion Privileges
Calgary, Alberta--(Newsfile Corp. - July 16, 2024) - Resverlogix Corp. (TSX: RVX) ("Resverlogix" or the "Company") announced it has entered into definitive transaction documents for the two-year extension of the Company's US$6.0 million secured convertible debenture (the "Debenture") with Shenzhen Hepalink Pharmaceutical Group Co., Ltd. ("Hepalink") (and payment of accrued interest thereon), extending the maturity date to May 13, 2026. As previously announced, in connection with the extension, H
NewsfileResverlogix Announces Updated Annual and Special Meeting of Shareholders
Calgary, Alberta--(Newsfile Corp. - May 28, 2024) - Resverlogix Corp. (TSX: RVX) ("Resverlogix" or the "Company") announced today that its Annual and Special Meeting of Shareholders (the "Meeting") will be held on Wednesday, July 31, 2024, commencing at approximately 1:00 pm (MT), as opposed to as previously scheduled for June 27, 2024.A Notice of Meeting and Management Information Circular, containing the matters to be considered at the Meeting, will be delivered to shareholders and ...
